- Home
- LBRDP vs SIGA Comparison
LBRDP vs SIGA Comparison
Compare LBRDP & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LBRDP
- SIGA
- Stock Information
- Founded
- LBRDP N/A
- SIGA 1995
- Country
- LBRDP United States
- SIGA United States
- Employees
- LBRDP 1900
- SIGA N/A
- Industry
- LBRDP Cable & Other Pay Television Services
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- LBRDP Telecommunications
- SIGA Health Care
- Exchange
- LBRDP Nasdaq
- SIGA Nasdaq
- Market Cap
- LBRDP N/A
- SIGA 422.9M
- IPO Year
- LBRDP N/A
- SIGA 1997
- Fundamental
- Price
- LBRDP $25.12
- SIGA $6.77
- Analyst Decision
- LBRDP
- SIGA
- Analyst Count
- LBRDP 0
- SIGA 0
- Target Price
- LBRDP N/A
- SIGA N/A
- AVG Volume (30 Days)
- LBRDP N/A
- SIGA 388.3K
- Earning Date
- LBRDP N/A
- SIGA 07-31-2025
- Dividend Yield
- LBRDP N/A
- SIGA 8.70%
- EPS Growth
- LBRDP N/A
- SIGA N/A
- EPS
- LBRDP N/A
- SIGA 0.67
- Revenue
- LBRDP N/A
- SIGA $120,330,310.00
- Revenue This Year
- LBRDP N/A
- SIGA N/A
- Revenue Next Year
- LBRDP N/A
- SIGA $95.31
- P/E Ratio
- LBRDP N/A
- SIGA $10.09
- Revenue Growth
- LBRDP N/A
- SIGA N/A
- 52 Week Low
- LBRDP N/A
- SIGA $4.95
- 52 Week High
- LBRDP N/A
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- LBRDP 66.35
- SIGA 61.28
- Support Level
- LBRDP $24.84
- SIGA $6.34
- Resistance Level
- LBRDP $25.13
- SIGA $7.07
- Average True Range (ATR)
- LBRDP 0.16
- SIGA 0.22
- MACD
- LBRDP -0.00
- SIGA 0.02
- Stochastic Oscillator
- LBRDP 82.22
- SIGA 71.70
About LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.